CytoTools AG
Symbol: T5O.DE
XETRA
0.406
EURMarktpreis heute
-4.2935
P/E-Verhältnis
0.0000
PEG-Verhältnis
2.02M
MRK Kapital
- 0.00%
DIV Rendite
CytoTools AG (T5O-DE) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 5.84 | 1.8 | 0 | 1.6 | ||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | -0.2 | ||||||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.other-current-assets | 0.27 | 0.1 | 0.1 | 0.1 | ||||||||||||||
balance-sheet.row.total-current-assets | 6.24 | 2 | 0.1 | 1.7 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0.1 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0.1 | ||||||||||||||
balance-sheet.row.long-term-investments | 79.62 | 19.7 | 18.2 | 20.5 | ||||||||||||||
balance-sheet.row.tax-assets | -20.16 | 0 | 0 | 20.6 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 0.53 | -19.7 | -18.2 | -20.6 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 79.66 | 19.7 | 18.2 | 20.6 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 85.89 | 21.6 | 18.3 | 22.3 | ||||||||||||||
balance-sheet.row.account-payables | 0.16 | 0 | 0.1 | 0.1 | ||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0 | 0.1 | 0 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0.1 | 0 | ||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.08 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | 0.28 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0.33 | 0.1 | 0.2 | 0.3 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-liab | 0.77 | 0.2 | 0.4 | 0.4 | ||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 20.55 | 5.1 | 4 | 4 | ||||||||||||||
balance-sheet.row.retained-earnings | -86.42 | -21.4 | -20.6 | -16.6 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 76.34 | 0.4 | 0.4 | 34.5 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 74.59 | 37.3 | 34 | 0 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 85.05 | 21.4 | 17.9 | 21.9 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 85.82 | 21.6 | 18.3 | 22.3 | ||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-equity | 85.05 | 21.4 | 17.9 | 21.9 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 85.82 | - | - | - | ||||||||||||||
Total Investments | 79.62 | 19.7 | 18.2 | 20.3 | ||||||||||||||
balance-sheet.row.total-debt | 0 | 0 | 0.1 | 0 | ||||||||||||||
balance-sheet.row.net-debt | -5.84 | -1.8 | 0.1 | -1.6 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -0.66 | -0.8 | -4.1 | -1.8 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 2.5 | 0 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.change-in-working-capital | 0.01 | -0.1 | -0.1 | 0.2 | ||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.inventory | 0.01 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-working-capital | 0 | -0.1 | -0.1 | 0.2 | ||||||||||||||
cash-flows.row.other-non-cash-items | 0.07 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -0.58 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -0.1 | 0 | ||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -1.5 | 0 | -4.8 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-investing-activites | -1.97 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -1.97 | -1.5 | -0.1 | -4.8 | ||||||||||||||
cash-flows.row.debt-repayment | 0 | -0.1 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-issued | 0 | 4.4 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.other-financing-activites | -0.16 | 0 | 0 | 6 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -0.16 | 4.2 | 0 | 6 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.net-change-in-cash | -2.72 | 1.8 | -1.7 | -0.4 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | -2.72 | 1.8 | -0.1 | 1.6 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 0 | 1.6 | 2 | ||||||||||||||
cash-flows.row.operating-cash-flow | -0.58 | -0.9 | -1.6 | -1.7 | ||||||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -0.1 | 0 | ||||||||||||||
cash-flows.row.free-cash-flow | -0.58 | -0.9 | -1.7 | -1.7 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0.02 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0.5 | 0.7 | ||||||||||||||
income-statement-row.row.gross-profit | 0.02 | 0 | -0.5 | -0.7 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.operating-expenses | 0.71 | 0.8 | 1.6 | 1.1 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 0.71 | 0.8 | 1.6 | 1.9 | ||||||||||||||
income-statement-row.row.interest-income | 0.02 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0.02 | 0 | -2.5 | 0 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.total-operating-expenses | 0.02 | 0 | -2.5 | 0 | ||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0 | 2.5 | 0 | ||||||||||||||
income-statement-row.row.ebitda-caps | -0.68 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | -0.69 | -0.8 | -1.6 | -1.8 | ||||||||||||||
income-statement-row.row.income-before-tax | -0.66 | -0.8 | -4 | -1.8 | ||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.net-income | -0.66 | -0.8 | -4.1 | -1.8 |
Häufig gestellte Frage
Wie hoch ist die CytoTools AG (T5O.DE) Gesamtvermögen?
CytoTools AG (T5O.DE) Gesamtvermögen ist 21607950.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 12412.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 1.000.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -0.082.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -29.508.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -30.361.
Was ist der CytoTools AG (T5O.DE) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -829837.250.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 0.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 835230.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 1081631.000.